RE:RE:Insight into Argonaut Gold’s Q4’23 and Year-End Performance During 2024, the company received term sheets from several potential lenders which are under consideration. The company is evaluating its options and plans to close by the end of April 2024. As for the waiver on the covenant, I’m not concerned that they won’t be able to get the waiver; the company has been waiving the conditions for 2 or more quarters now.
The balance sheet is okay. Cash and equivalents of US$83.8 million, including US$58.231 million in working capital. The book value increased to US$967.434 million and BV/S is US$0.887 per share.
As for the conjecture, the company made no mention of share restructuring. I already explained the process of share consolidation and I’m not going to explain again, as you’re wasting my time.
Here are the averages for each type of share and convertible debt for the year 2023:
Options: The company had 2,057,395 options remaining with a weighted average exercise price of CA$1.90.
Restricted Stock Units (RSUs): The company had 9,626,025 RSUs remaining with a weighted average fair value of CA$0.56.
Performance Stock Units (PSUs): The company had 6,126,800 PSUs remaining with a weighted average fair value of CA$0.79.
Deferred Share Units (DSUs): The company had 2,507,772 DSUs remaining with a weighted average exercise price of CA$0.90.
Alio Replacement Options: The company had 76,868 Alio Replacement Options in circulation, with a weighted average exercise price of CA$4.12 per share.
Convertible Debentures: The balance of the outstanding Convertible Debentures was $57.5 million, with a conversion price of $2.86 per common share.
Lastly, I’m Wolseley, that’s me. Did you seriously think my name was Argonaut Gold or what?